AMGN US0311621009

Report

Delayed Nasdaq - 04:00 2022-12-09 pm EST
278.65	USD		-2.42%

12/07	Amgen : When It Comes to Biosimilar Manufacturing, Heritage and Expertise Matter	PU
12/07	Amgen : Investor Presentation December 2022	PU
12/07	Amgen : Alliances Help Connect Patients with Lung Cancer to Precision Medicine Treatments	PU

Calendar

Event chart AMGEN INC.

Upcoming events on AMGEN INC.

02/02/23		FY 2022 Earnings Release (Projected)
04/26/23		Q1 2023 Earnings Release (Projected)
08/01/23		Interim 2023 Earnings Release (Projected)
10/31/23		Q3 2023 Earnings Release (Projected)

Past events on AMGEN INC.

12/05/22 \| 08:00am		World Insulin Resistance, Diabetes & Cardiovascular Disease Congress
11/29/22 \| 11:20am		Evercore ISI HealthCONx Conference
11/16/22		Ex-dividend day for
11/14/22 \| 03:00pm		American college of rheumatology convergence conference - abstract no : #1275040
11/14/22 \| 01:00pm		American college of rheumatology convergence conference - abstract no : #1289316
11/13/22 \| 03:00pm		American college of rheumatology convergence conference - abstract no : #1588
11/13/22 \| 01:00pm		American college of rheumatology convergence conference - abstract no : #1425
11/13/22 \| 10:15am		American college of rheumatology convergence conference - abstract no: #1076
11/13/22 \| 10:15am		American college of rheumatology convergence conference - abstract no: #1077
11/13/22 \| 09:10am		American college of rheumatology convergence conference - abstract no: #1078

Past dividends on AMGEN INC.

11/16/22		Quarterly 1.94 USD
08/17/22		Quarterly 1.94 USD
05/16/22		Quarterly 1.94 USD
02/14/22		Quarterly 1.94 USD
11/15/21		Quarterly 1.76 USD
08/16/21		Quarterly 1.76 USD
05/14/21		Quarterly 1.76 USD
02/11/21		Quarterly 1.76 USD
11/13/20		Quarterly 1.6 USD
08/14/20		Quarterly 1.6 USD

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	22 849 22 894 -0,20%	23 747 23 351 1,7%	23 362 23 196 0,71%	25 424 25 363 0,24%	25 979 25 998 -0,07%	26 241
Operating income (EBITDA) M $	Released Forecast Spread	13 613 13 581 0,23%	13 803 13 681 0,89%	13 363 13 029 2,6%	15 935 15 167 5,1%	15 822 16 002 -1,1%	15 902
Operating profit (EBIT) M $	Released Forecast Spread	11 658 11 959 -2,5%	11 857 11 786 0,60%	11 157 11 138 0,17%	12 334 12 315 0,15%	12 424 12 461 -0,30%	12 714
Pre-Tax Profit (EBT) M $	Released Forecast Spread	9 597 9 777 -1,8%	9 545 9 487 0,61%	9 138 9 499 -3,8%	8 133 8 782 -7,4%	6 701 6 317 6,1%	7 470
Net income M $	Released Forecast Spread	1 979 2 190 -9,6%	8 394 8 346 0,57%	7 842 7 850 -0,10%	7 264 7 163 1,4%	5 893 5 575 5,7%	6 552
EPS $	Released Forecast Spread	2,69 2,98 -9,7%	12,6 12,4 1,4%	12,9 12,8 0,40%	12,3 12,0 2,4%	10,3 9,81 4,8%	12,1
Announcement Date		02/01/2018	01/29/2019	01/30/2020	02/02/2021	02/07/2022	-

Quarterly results

Fiscal Period : December

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

2022 Q4

Sales
M $

Released
Forecast
Spread

6 706
6 690
0,23%

6 846
6 869
-0,33%

6 238
6 111
2,1%

6 594
6 526
1,0%

6 652
6 556
1,5%

6 766

Operating income
(EBITDA)
M $

Released
Forecast
Spread

4 302
4 147
3,7%

3 849
3 952
-2,6%

3 981
3 747
6,2%

4 163
3 953
5,3%

4 114
4 068
1,1%

3 689

Operating profit
(EBIT)
M $

Released
Forecast
Spread

3 452
3 232
6,8%

2 997
3 049
-1,7%

3 140
2 939
6,8%

3 335
3 152
5,8%

3 277
3 201
2,4%

2 953

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

2 155
2 274
-5,2%

2 131
1 888
13%

1 675
2 243
-25%

1 531
2 046
-25%

2 392
2 021
18%

1 884

Net income
M $

Released
Forecast
Spread

1 884
1 940
-2,9%

1 899
1 631
16%

1 476
1 725
-14%

1 317
1 749
-25%

2 143
1 665
29%

1 613

EPS
$

Released
Forecast
Spread

3,31
3,44
-3,9%

3,36
2,99
12%

2,68
3,24
-17%

2,45
3,28
-25%

3,98
3,06
30%

3,06

Announcement Date

11/02/2021

02/07/2022

04/27/2022

08/04/2022

11/03/2022

Previous year

Next Year

Upcoming sector events for AMGEN INC.

01/24/23		JOHNSON & JOHNSON : FY 2022 Earnings Release
01/27/23		ABBVIE INC. : FY 2022 Earnings Release (Projected)
01/31/23		PFIZER INC. : FY 2022 Earnings Release (Projected)
02/01/23		NOVO NORDISK A/S : FY 2022 Earnings Release
02/02/23		ELI LILLY AND COMPANY : FY 2022 Earnings Release (Projected)
04/18/23		JOHNSON & JOHNSON : Q1 2023 Earnings Release (Projected)
04/25/23		ELI LILLY AND COMPANY : Q1 2023 Earnings Release (Projected)
04/27/23		ABBVIE INC. : Q1 2023 Earnings Release (Projected)
05/02/23		PFIZER INC. : Q1 2023 Earnings Release (Projected)
05/03/23		NOVO NORDISK A/S : Q1 2023 Earnings Release (Projected)

More events

Past sector events for AMGEN INC.

11/02/22 \| 01:30am		NOVO NORDISK A/S : Q3 2022 Earnings Release
11/01/22 \| 05:45am		PFIZER INC. : Q3 2022 Earnings Release
11/01/22 \| 05:25am		ELI LILLY AND COMPANY : Q3 2022 Earnings Release
10/28/22 \| 07:44am		ABBVIE INC. : Q3 2022 Earnings Release
10/18/22 \| 06:25am		JOHNSON & JOHNSON : Q3 2022 Earnings Release
08/04/22 \| 06:25am		ELI LILLY AND COMPANY : Interim 2022 Earnings Release
08/03/22 \| 01:30am		NOVO NORDISK A/S : Interim 2022 Earnings Release
07/29/22 \| 07:41am		ABBVIE INC. : Interim 2022 Earnings Release
07/28/22 \| 06:45am		PFIZER INC. : Interim 2022 Earnings Release
07/19/22 \| 06:45am		JOHNSON & JOHNSON : Interim 2022 Earnings Release

More events

Analysis

J&J sues Amgen over plan to sell ulcerative colitis drug similar to Stelara